Tilray CEO Irwin Simon highlights the significant market opportunity awaiting the company if US cannabis restrictions are eased. The firm currently maintains no direct cannabis sales in the US market.
- CEO Irwin Simon identifies US market entry as a major growth driver
- Tilray currently lacks a direct cannabis sales presence in the US
- Regulatory reclassification is viewed as the primary catalyst for expansion
- Potential for significant scale if federal restrictions are lifted
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.